VPTDF - VentriPoint Diagnostics Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD

VentriPoint Diagnostics Ltd.

Livingston Place West
Suite 1000 250 ? 2nd Avenue S.W.
Calgary, AB T2P 0C1


IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. George AdamsCEO & Director193.64kN/AN/A
Ms. Ellen BriantCFO & Corp. Sec.84.36kN/AN/A
Mr. Desmond HirsonPresN/AN/AN/A
Dr. Alvira Macanovic Ph.D.VP of Devel. & OperationsN/AN/AN/A
Mr. Mehran MehrtashVP of Worldwide Distributor SalesN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in China and Europe. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. The company is based in Calgary, Canada.

Corporate Governance

VentriPoint Diagnostics Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.